Community Research and Development Information Service - CORDIS

Clinical validation of a serum protein biomarker signature for the early diagnosis of pancreatic cancer.

From 2015-06-01 to 2018-05-31, closed project | IMMPACT Website

Project details

Total cost:

EUR 4 244 969,25

EU contribution:

EUR 4 244 969

Coordinated in:

Sweden

Call for proposal:

H2020-SMEINST-2-2014See other projects for this call

Funding scheme:

SME-2 - SME instrument phase 2

Objective

Coordinator

IMMUNOVIA AB
Sweden

EU contribution: EUR 4 244 969


SCHEELEVAGEN 2 MEDICON VILLAGE
223 81 LUND
Sweden
See on map
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Contact the organisation

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top